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ment modality for this subgroup.
1031: REVIEW OF UROLITHIASIS INVESTIGATION & MANAGEMENT
PROTOCOLS AT RURAL DGH; USING IVU AS AN INITIAL RADIOLOGICAL
INVESTIGATION
Laith Alzweri *,2, Gwenllian Davies 1, Kyriacos Alexandrou 1,
Ernest Ahiaku 1. 1Ysbyty Gwynedd, Bangor, UK; 2University Hospital of North
Staffordshire, Stoke On Trent, UK.
Introduction: Review local practice for investigating cases with suspected
urolithiasis using IVU.
Methods: Prospective collection of data (April-Aug) 2013.
Results: Total of 50 patients median age 53.3 years (22-85), 70%males (35)
and 30% females (15). 66% (33) had urolithiasis previously. 96% (48) had X-
Ray KUB, 72 %( 36) had IVU and 46% (23) had NCCT. Only 22% (11) had NCCT
as initial radiological investigation overall. Of the 23 patients who had
NCCT, 52.17 %( 12), it was preceded by IVU on same admission. 33% of
patients who had IVU initially required additional NCCT. 50% of patients
who had NCCT had a potentially avoidable IVU, if they have had NCCT
initially.
Conclusions: If all patients had NCCT as the only investigative mo-
dality. They would have avoided potential extra radiation exposure in
96% of X-ray KUB, and 72% of IVU to reach diagnosis. NCCT is more
effective than IVU with sensitivity (94-97%) and speciﬁcity (92-100%)
compared with (51-87%) sensitivity and (92-100%) speciﬁcity;
accordingly. The current evidence supports the NCCT as gold standard
for investigating suspected urolithiasis cases. This audit has resulted in
change of local protocols in the form of using NCCT for all suspected
acute urolithiasis cases.
1042: IMPACT OF PCNL TECHNIQUE ON PATIENT SATISFACTION AND
COMPARISON WITH URETERO-RENOSCOPY FOR RENAL STONES
Dev Gulur 1, Tsong Kwong *,1, Shankar Chandrasekhran 1,
Graham Watson 2, Mahmoud Elfar 1. 1Aintree University Hospital, London,
UK; 2Eastbourne Hospital, Eastbourne, UK.
Introduction: Percutaneous nephrolithotomy (PCNL) is considered more
morbid than ﬂexible ureteroscopy (FURS) but PCNL has evolved with the
advent of minipercs and tubeless techniques. Both procedures were
evaluated for post-operative pain & time to recovery.
Methods: 17 patients having 24Fr tubeless PCNL, 26 having ﬂexible
uretero-renoscopy (FURS) and 16 had tubed 30Fr PCNL. Post-operative
pain and duration were assessed using Visual analogue Score (VAS). The
total analgesic consumption and time to normal activities were
measured.
Results: 60% of 24Fr PCNL patients had no pain following surgery
compared to 40% after FURS. 97% of 30Fr PCNL had pain. Mean VAS and
duration of painwere lower for 24Fr PCNL compared to FURS but higher for
30Fr PCNL. Analgesic requirements in 24Fr PCNL compared to FURS pa-
tients was less for opioid but more for NSAIDs. 30Fr PCNL had higher
analgesia mainly opioid. Mean time to return to normal activities was
longer in 24Fr PCNL compared to FURS and longest for 30Fr PCNL.
Conclusions: The use of smaller sheaths and tubeless techniques in
PCNL is as well tolerated, or even better tolerated than FURS with
reduced post-operative stay, less analgesia and quicker return to normal
activity.
1067: NOVEL USE OF AIR IN THULIUM AND HOLMIUM LASER ABLATION
OF BLADDER TRANSITIONAL CELL CARCINOMA
Dev Gulur 1, Tsong Kwong *,1, Graham Watson 2, Mahmoud Elfar 1. 1Aintree
University Hospital, Liverpool, UK; 2Eastbourne Hospital, Eastbourne, UK.
Introduction: Holmium and Thulium LASER ablation of superﬁcial
bladder tumours using 0.9%NaCl for cystodistension is well established.
This study aims to evaluate the efﬁcacy of these LASERs using air for
cystodistension.
Methods: 20 patients with muscle invasive, non-operable bladder TCC,
recurrent bleeding and poor performance status and 20 patients with
recurrent superﬁcial bladder TCC had Thulium/Holmium ablation. Mean
tumour size was 3cm. Intravesical levo-bupivicaine and lidocaine gel was
given pre-procedure. 50 ml syringe was used through the ﬂexible cysto-
scope to empty the bladder and introduce 200-300 ml of air. Regular
smoke evacuation was done. 10-20 watts power was used for muscleinvasive tumours and 5-10 watts for superﬁcial tumours. The mean
operative duration was 20 minutes.
Results: The procedures were well tolerated with no intra or post-oper-
ative pain or haematuria. 3 month check cystoscopy showed no recurrence
in all superﬁcial cases. In the palliative group, the procedure had to be
repeated in 3 months to ensure local control.
Conclusions: Using air for cystodistension has proven to be safe allowing
fast vaporisation of large bladder tumours under local anaesthesia. It
helped to improve visualisation in bleeding tumours, and easily reached
tumours which would be difﬁcult with a resectoscope.
1077: HEALTH-RELATED QUALITY OF LIFE (HRQOL) OUTCOMES IN MEN
TREATED WITH LAPAROSCOPIC RADICAL PROSTATECTOMY (LRP) FOR
LOCALISED PROSTATE CANCER
Ahmed Abroaf, Kimberley Edwards *, Ameet Patel, N. Brown,
Naeem Soomro, Anna O'Riordan. Freeman Hospital, Newcastle upon Tyne,
UK.
Introduction: LRP results in good survival rates, however treatment can
have adverse effects. With current emphasis on quality of life of cancer
patients it is important that HRQoL issues are carefully examined. The
FACT-P (Functional assessment of cancer therapy prostate scale, Cella et al.
1993) was used to prospectively assess HRQoL effects of LRP in the ﬁrst
year of treatment.
Methods: The FACT-P was administered to patients before and 1-year
post-LRP between January 2010 and October 2011. The questionnaire
consists of 27 core items, which assess patient function in four domains:
Physical, Social/Family, Emotional, and Functional well-being, and 12 site-
speciﬁc items assessing prostate-related symptoms.
Results: 175 patients underwent LRP in the study period. Completed forms
were returned by 42% (n¼72). The mean score pre and post-treatment for
the FACT-P questionnaire was 100.3 (s.d.10.7) and 103.0 (s.d.13.6) respec-
tively, which demonstrates slight improvement post LRP (t-Test: p¼0.036).
These improvements were noted particularly in the emotional and pros-
tate cancer speciﬁc domains.
Conclusions: Overall our study shows slight improvement in HRQoL
following LRP. HRQoL assessment can be used for counselling patients
undergoing prostatectomy with regards to long-term expectations.
Therefore we conclude that this tool should be used routinely in prostate
cancer management.
1137: INTRAVESICAL BACILE CALMETTE GUERIN IN HIGH-RISK NON-
MUSCLE INVASIVE BLADDER CANCER: PATIENT OUTCOMES AND
ADHERENCE TO EUROPEAN ASSOCIATION OF UROLOGY GUIDELINES
Zoe Gates *, Mark Kitchen, Lyndon Gommersall. University Hospital North
Staffordshire, West Midlands, UK.
Introduction: To assess compliance with European Association of Urology
(EAU) guidelines in managing high-risk non-muscle invasive bladder
cancer (NMIBC) with intravesical Bacile Calmette Guerin (BCG), and to
evaluate patient clinical outcomes.
Methods: A retrospective analysis was carried out, with local Trust
approval, on 50 patients newly diagnosed with high-risk NMIBC, between
2011 and 2013. All patients receiving intravesical BCG were included.
Those unﬁt for BCG and choosing not to receive BCG were excluded.
Timing, dosing and clinical outcomes were evaluated.
Results: Recurrencewas deﬁned as a single recurrence of tumour of similar
or lower grade or stage; progression was deﬁned as multifocal tumour
recurrence, new carcinoma in-situ, upstaging, metastases, or disease-
speciﬁcmortality. 41/50 patients commenced BCG afterMDT discussion. 4/
41 did not tolerate BCG induction due to side effects, 3 of which suffered
recurrence or progression. 5/41 had recurrence or progression within the
BCG induction period. 23/41 were recurrence or progression free; 3 and 4
patients suffered recurrence or progression respectively despite BCG;
2 patients stopped BCG prematurely due to a National shortage.
Conclusions: Current patient management at our centre adheres to EAU
guidelines. Moreover, intravesical BCG appears an effective agent in the
reduction of high-risk NMIBC recurrence and progression.
1175: TURBT e DO JUNIOR TRAINEE (ST3) PERFORMED RESECTIONS
COMPROMISE QUALITY?
Adam Bennett *, Nicholas Roberts-Huntley, Owen Hughes,
Krishna Narahari. University Hospital of Wales, Cardiff, UK.
